Severe COVID-19 in Chronic Liver Disease Linked With Cholestasis and Secondary Sclerosing Cholangitis Severe COVID-19 in Chronic Liver Disease Linked With Cholestasis and Secondary Sclerosing Cholangitis
Severe COVID-19 increases the risk for cholestasis and secondary sclerosing cholangitis in patients with chronic liver disease, researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Cholestasis | COVID-19 | Health | Infectious Diseases | Liver | Liver Disease | Urology & Nephrology